The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Updated efficacy and quality-of-life (QoL) analyses in OPTIMAL, a phase III, randomized, open-label study of first-line erlotinib versus gemcitabine/carboplatin in patients with EGFR-activating mutation-positive (EGFR Act Mut+) advanced non-small cell lung cancer (NSCLC).
C. Zhou
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
Y. L. Wu
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
G. Chen
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
J. F. Feng
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
X. Liu
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
C. Wang
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
S. Zhang
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
J. Wang
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
S. Zhou
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
S. Ren
No relevant relationships to disclose
S. Lu
Research Funding - Chinese Thoracic Oncology Group; Roche; Shanghai Pulmonary Hospital; Tongji University
L. Zhang
No relevant relationships to disclose